On the public citation graph
Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer
0 signed · 425 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/humu.22552openalex-snapshot
TP53 Mutations in Human Cancer: Database Reassessment and Prospects for the Next Decade
inferredcites →https://doi.org/10.1002/ijc.24237openalex-snapshot
Spleen tyrosine kinase as a novel candidate tumor suppressor gene for human oral squamous cell carcinoma
inferredcites →https://doi.org/10.1002/ijc.2910410204openalex-snapshot
P53 expression in breast cancer
inferredcites →https://doi.org/10.1002/path.4185openalex-snapshot
Germline and somatic polymerase ϵ and δ mutations define a new class of hypermutated colorectal and endometrial cancers
inferredcites →https://doi.org/10.1002/path.4380openalex-snapshot
Regional biases in mutation screening due to intratumoural heterogeneity of prostate cancer
inferredcites →https://doi.org/10.1007/s10585-013-9617-2openalex-snapshot
Percutaneous image-guided biopsy of prostate cancer metastases yields samples suitable for genomics and personalised oncology
inferredcites →https://doi.org/10.1016/j.canlet.2005.11.004openalex-snapshot
The Syk tyrosine kinase: A new negative regulator in tumor growth and progression
inferredcites →https://doi.org/10.1016/j.ccr.2010.05.026openalex-snapshot
Integrative Genomic Profiling of Human Prostate Cancer
inferredcites →https://doi.org/10.1016/j.ccr.2013.01.002openalex-snapshot
Integrative Genomic Analyses Reveal an Androgen-Driven Somatic Alteration Landscape in Early-Onset Prostate Cancer
inferredcites →https://doi.org/10.1016/j.ccr.2013.04.025openalex-snapshot
Chromoplexy: A New Category of Complex Rearrangements in the Cancer Genome
inferredcites →https://doi.org/10.1016/j.cell.2004.11.004openalex-snapshot
Mutant p53 Gain of Function in Two Mouse Models of Li-Fraumeni Syndrome
inferredcites →https://doi.org/10.1016/j.cell.2004.11.006openalex-snapshot
Gain of Function of a p53 Hot Spot Mutation in a Mouse Model of Li-Fraumeni Syndrome
inferredcites →https://doi.org/10.1016/j.cell.2012.04.023openalex-snapshot
The Life History of 21 Breast Cancers
inferredcites →https://doi.org/10.1016/j.cell.2012.04.024openalex-snapshot
Mutational Processes Molding the Genomes of 21 Breast Cancers
inferredcites →https://doi.org/10.1016/j.cell.2013.03.021openalex-snapshot
Punctuated Evolution of Prostate Cancer Genomes
inferredcites →https://doi.org/10.1016/j.celrep.2012.12.008openalex-snapshot
Deciphering Signatures of Mutational Processes Operative in Human Cancer
inferredcites →https://doi.org/10.1016/j.eururo.2013.05.029openalex-snapshot
The Mutational Landscape of Prostate Cancer
inferredcites →https://doi.org/10.1016/j.gde.2013.11.014openalex-snapshot
Mutational signatures: the patterns of somatic mutations hidden in cancer genomes
inferredcites →https://doi.org/10.1016/j.urology.2005.06.108openalex-snapshot
Prognostic impact of positive surgical margins in surgically treated prostate cancer: Multi-institutional assessment of 5831 patients
inferredcites →https://doi.org/10.1016/j.urolonc.2013.08.025openalex-snapshot
The prostate cancer genome: Perspectives and potential
inferredcites →https://doi.org/10.1038/modpathol.2012.162openalex-snapshot
PTEN losses exhibit heterogeneity in multifocal prostatic adenocarcinoma and are associated with higher Gleason grade
inferredcites →https://doi.org/10.1038/nature09460openalex-snapshot
The patterns and dynamics of genomic instability in metastatic pancreatic cancer
inferredcites →https://doi.org/10.1038/nature09515openalex-snapshot
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
inferredcites →https://doi.org/10.1038/nature09744openalex-snapshot
The genomic complexity of primary human prostate cancer
inferredcites →https://doi.org/10.1038/nature11125openalex-snapshot
The mutational landscape of lethal castration-resistant prostate cancer
inferredcites →https://doi.org/10.1038/nature12477openalex-snapshot
Signatures of mutational processes in human cancer
inferredcites →https://doi.org/10.1038/ncomms3997openalex-snapshot
Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
inferredcites →https://doi.org/10.1038/ncomms5988openalex-snapshot
Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancer
inferredcites →https://doi.org/10.1038/ng.2279openalex-snapshot
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
inferredcites →https://doi.org/10.1038/ng.2503openalex-snapshot
Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas
inferredcites →https://doi.org/10.1038/ng.2921openalex-snapshot
Recurrent PTPRB and PLCG1 mutations in angiosarcoma
inferredcites →https://doi.org/10.1038/nmeth.1974openalex-snapshot
The 1000 Genomes Project: data management and community access
inferredcites →https://doi.org/10.1038/nrurol.2012.185openalex-snapshot
The complexity of prostate cancer: genomic alterations and heterogeneity
inferredcites →https://doi.org/10.1038/srep02650openalex-snapshot
Comprehensive identification of mutational cancer driver genes across 12 tumor types
inferredcites →https://doi.org/10.1073/pnas.1009843107openalex-snapshot
Allele-specific copy number analysis of tumors
inferredcites →https://doi.org/10.1073/pnas.1108745108openalex-snapshot
Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers
inferredcites →https://doi.org/10.1093/bioinformatics/btp324openalex-snapshot
Fast and accurate short read alignment with Burrows–Wheeler transform
inferredcites →https://doi.org/10.1093/bioinformatics/btr665openalex-snapshot
SomaticSniper: identification of somatic point mutations in whole genome sequencing data
inferredcites →https://doi.org/10.1093/bioinformatics/btt767openalex-snapshot
Socrates: identification of genomic rearrangements in tumour genomes by re-aligning soft clipped reads
inferredcites →https://doi.org/10.1093/nar/gkh073openalex-snapshot
Database resources of the National Center for Biotechnology Information: update
inferredcites →https://doi.org/10.1093/nar/gkq603openalex-snapshot
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
inferredcites →https://doi.org/10.1093/nar/gks540openalex-snapshot
RobiNA: a user-friendly, integrated software solution for RNA-Seq-based transcriptomics
inferredcites →https://doi.org/10.1093/nar/gkt1146openalex-snapshot
Database resources of the National Center for Biotechnology Information
inferredcites →https://doi.org/10.1101/gad.229559.113openalex-snapshot
Chromothripsis and beyond: rapid genome evolution from complex chromosomal rearrangements
inferredcites →https://doi.org/10.1126/science.1181498openalex-snapshot
Human Genome Sequencing Using Unchained Base Reads on Self-Assembling DNA Nanoarrays
inferredcites →https://doi.org/10.1126/science.1253462openalex-snapshot
Spatial and temporal diversity in genomic instability processes defines lung cancer evolution
inferredcites →https://doi.org/10.1126/science.1256930openalex-snapshot
Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing
inferredcites →https://doi.org/10.1126/scitranslmed.3003726openalex-snapshot
Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA
inferredcites →https://doi.org/10.1126/scitranslmed.3009448openalex-snapshot
Tumor clone dynamics in lethal prostate cancer
inferredcites →https://doi.org/10.1158/1078-0432.ccr-12-3606openalex-snapshot
Genomic Profiling Defines Subtypes of Prostate Cancer with the Potential for Therapeutic Stratification
inferredcites →https://doi.org/10.1186/gb-2009-10-3-r25openalex-snapshot
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome
inferredcites →https://doi.org/10.1186/gb-2013-14-4-r36openalex-snapshot
TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions
inferredcites →https://doi.org/10.1371/journal.pgen.1000529openalex-snapshot
A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies
inferredcites →https://doi.org/10.4149/neo_2011_01_89openalex-snapshot
Research on the reactivation of Syk expression caused by the inhibition of DNA promoter methylation in the lung cancer
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.3245216openalex-extracted
MSH2 is Inactivated by Multiple Mechanisms in Prostate Tumors, Leading to a Distinct Immune Response and Clinical Outcome Compared to MSH2 Deficient Colorectal Cancer
inferred← citeshttps://doi.org/10.1001/jamaoncol.2016.0494openalex-snapshot
Genomic Alterations in Cell-Free DNA and Enzalutamide Resistance in Castration-Resistant Prostate Cancer
inferred← citeshttps://doi.org/10.1002/1878-0261.12923openalex-snapshot
Epigenetic and transcriptional analysis reveals a core transcriptional program conserved in clonal prostate cancer metastases
inferred← citeshttps://doi.org/10.1002/9783527813933.ch14openalex-snapshot
Strain‐Tuning of 2 D Transition Metal Dichalcogenides
inferred← citeshttps://doi.org/10.1002/advs.202203400openalex-snapshot
Carrier Multiplication in Transition Metal Dichalcogenides Beyond Threshold Limit
inferred← citeshttps://doi.org/10.1002/cam4.6292openalex-snapshot
The role of cytoreductive radical prostatectomy and lymph node dissection in bone‐metastatic prostate cancer: A population‐based study
inferred← citeshttps://doi.org/10.1002/cncr.31860openalex-snapshot
Oligometastatic prostate cancer: Reality or figment of imagination?
inferred← citeshttps://doi.org/10.1002/gcc.22824openalex-snapshot
Discordant and heterogeneous clinically relevant genomic alterations in circulating tumor cells vs plasma DNA from men with metastatic castration resistant prostate cancer
inferred← citeshttps://doi.org/10.1002/ijc.32594openalex-snapshot
Transcriptional profiling of breast cancer‐associated lymphatic vessels reveals VCAM‐1 as regulator of lymphatic invasion and permeability
inferred← citeshttps://doi.org/10.1002/ijc.35327openalex-snapshot
Epigenomics‐guided precision oncology: Chromatin variants in prostate tumor evolution
inferred← citeshttps://doi.org/10.1002/nano.202300175openalex-snapshot
Role of vacancy defects and nanopumping on drug transport efficiency in boron nitride nanotubes
inferred← citeshttps://doi.org/10.1002/path.5604openalex-snapshot
High‐grade tumours promote growth of other less‐malignant tumours in the same prostate
inferred← citeshttps://doi.org/10.1002/path.5887openalex-snapshot
Comparative genomics of primary prostate cancer and paired metastases: insights from 12 molecular case studies
inferred← citeshttps://doi.org/10.1002/path.6472openalex-snapshot
Tracing metastatic spread in pediatric solid tumors using copy number and targeted deep sequencing
inferred← citeshttps://doi.org/10.1002/pros.23260openalex-snapshot
Beyond Seed and Soil: Understanding and Targeting Metastatic Prostate Cancer; Report From the 2016 Coffey–Holden Prostate Cancer Academy Meeting
inferred← citeshttps://doi.org/10.1002/pros.23278openalex-snapshot
Blind Biobanking of the Prostatectomy Specimen: Critical Evaluation of the Existing Techniques and Development of the New 4-Level Tissue Extraction Model With High Sampling Efficacy
inferred← citeshttps://doi.org/10.1002/pros.23729openalex-snapshot
Tumor cell heterogeneity and resistance; report from the 2018 Coffey‐Holden Prostate Cancer Academy Meeting
inferred← citeshttps://doi.org/10.1002/pros.23952openalex-snapshot
A qualitative transcriptional signature for predicting the biochemical recurrence risk of prostate cancer patients after radical prostatectomy
inferred← citeshttps://doi.org/10.1002/pros.24057openalex-snapshot
Feasibility and performance of a novel probe panel to detect somatic DNA copy number alterations in clinical specimens for predicting prostate cancer progression
inferred← citeshttps://doi.org/10.1002/pros.24353openalex-snapshot
The evolving landscape of prostate cancer somatic mutations
inferred← citeshttps://doi.org/10.1002/smtd.202000072openalex-snapshot
Wafer‐Scale Fabrication of Nanopore Devices for Single‐Molecule DNA Biosensing using MoS2
inferred← citeshttps://doi.org/10.1002/sstr.202100120openalex-snapshot
Scalably Nanomanufactured Atomically Thin Materials‐Based Wearable Health Sensors
inferred← citeshttps://doi.org/10.1007/174_2017_11openalex-snapshot
Radiotherapy in the Management of Prostate Cancer
inferred← citeshttps://doi.org/10.1007/978-3-030-16624-3_8openalex-snapshot
Crosstalk Between Prostate Cancer Stem Cells and Immune Cells: Implications for Tumor Progression and Resistance to Immunotherapy
inferred← citeshttps://doi.org/10.1007/978-3-030-31000-4_1openalex-snapshot
Unifying Next-Generation Biomarkers and Nanodiagnostic Platforms for Precision Prostate Cancer Management
inferred← citeshttps://doi.org/10.1007/978-3-030-32656-2_9openalex-snapshot
The Bone Microenvironment in Prostate Cancer Metastasis
inferred← citeshttps://doi.org/10.1007/978-3-030-80962-1_186-1openalex-snapshot
Synthetic-Based Tumor-Infiltrating Lymphocytes (TILs) in Adoptive Cell Therapies
inferred← citeshttps://doi.org/10.1007/978-3-031-09518-4_4openalex-snapshot
Targeting Metastatic Disease: Challenges and New Opportunities
inferred← citeshttps://doi.org/10.1007/978-3-031-11836-4_15openalex-snapshot
Prostate Cancer Epigenetic Plasticity and Enhancer Heterogeneity: Molecular Causes, Consequences and Clinical Implications
inferred← citeshttps://doi.org/10.1007/978-3-031-22903-9_12openalex-snapshot
Insight into Intratumoral Heterogeneity Through Single CTC Sequencing and CDX Analysis
inferred← citeshttps://doi.org/10.1007/978-3-032-00767-4_186openalex-snapshot
Synthetic-Based Tumor-Infiltrating Lymphocytes (TILs) in Adoptive Cell Therapies
inferred← citeshttps://doi.org/10.1007/978-3-319-49864-5_3openalex-snapshot
Personalized Medicine Through Advanced Genomics
inferred← citeshttps://doi.org/10.1007/978-3-319-55661-1_11openalex-snapshot
Liquid Biopsy in Prostate Cancer
inferred← citeshttps://doi.org/10.1007/978-3-319-55825-7_7openalex-snapshot
Modeling Cancer Metastasis
inferred← citeshttps://doi.org/10.1007/978-3-319-57424-0_8openalex-snapshot
Patient-Derived Xenograft Models of Prostate Cancer
inferred← citeshttps://doi.org/10.1007/978-3-319-64096-9_20openalex-snapshot
The Role of Androgen Receptor in Prostate Cancer
inferred← citeshttps://doi.org/10.1007/978-3-319-95693-0_5openalex-snapshot
MicroRNAs as Regulators of Prostate Cancer Metastasis
inferred← citeshttps://doi.org/10.1007/978-981-95-5945-9_2openalex-snapshot
Epidemiology, Genetics/Molecular and Screening of Urogenital Cancers
inferred← citeshttps://doi.org/10.1007/s00109-020-01874-2openalex-snapshot
Clinical implications of intratumor heterogeneity: challenges and opportunities
inferred← citeshttps://doi.org/10.1007/s00259-026-08049-0openalex-snapshot
68Ga-PSMA PET/CT in biochemically recurrent prostate cancer: association with genomic data
inferred← citeshttps://doi.org/10.1007/s00345-017-2119-0openalex-snapshot
Reconsidering the role of pelvic lymph node dissection with radical prostatectomy for prostate cancer in an era of improving radiological staging techniques
inferred← citeshttps://doi.org/10.1007/s00345-018-2542-xopenalex-snapshot
Developments in oligometastatic hormone-sensitive prostate cancer
inferred← citeshttps://doi.org/10.1007/s00345-018-2609-8openalex-snapshot
Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer: not ready for prime time
inferred← citeshttps://doi.org/10.1007/s00432-022-04352-zopenalex-snapshot
The impact of stereotactic ablative radiotherapy on oligoprogressive metastases from renal cell carcinoma
inferred← citeshttps://doi.org/10.1007/s10555-015-9597-6openalex-snapshot
The origin of prostate metastases: emerging insights
inferred← citeshttps://doi.org/10.1007/s10555-023-10094-2openalex-snapshot
Regulation of dormancy during tumor dissemination: the role of the ECM
inferred← citeshttps://doi.org/10.1007/s10585-022-10158-7openalex-snapshot
Oligoprogressive castration-resistant prostate cancer treated with metastases-directed stereotactic body radiation therapy: predictive factors for patients’ selection
inferred← citeshttps://doi.org/10.1007/s10585-023-10230-wopenalex-snapshot
Associations amongst genes, molecules, cells, and organs in breast cancer metastasis
inferred← citeshttps://doi.org/10.1007/s11033-025-11258-9openalex-snapshot
Uncovering the role of ETS2 in prostate cancer pathogenesis: relationship with p53 and ERG
inferred← citeshttps://doi.org/10.1007/s11912-019-0791-5openalex-snapshot
Trends in Management of Oligometastatic Hormone-Sensitive Prostate Cancer
inferred← citeshttps://doi.org/10.1007/s40291-019-00406-0openalex-snapshot
Detection of Circulating Tumor DNA with a Single-Molecule Sequencing Analysis Validated for Targeted and Immunotherapy Selection
inferred← citeshttps://doi.org/10.1016/b978-0-323-99884-0.00002-1openalex-snapshot
Circulating tumor cells and DNAs in prostate tumors
inferred← citeshttps://doi.org/10.1016/b978-0-443-13212-4.00019-2openalex-snapshot
Cancer stem cells and maintenance of tumor heterogeneity/microenvironment
inferred← citeshttps://doi.org/10.1016/j.addr.2015.12.011openalex-snapshot
Tumor lymphangiogenesis and new drug development
inferred← citeshttps://doi.org/10.1016/j.ajpath.2019.02.009openalex-snapshot
Syntaphilin Is a Novel Biphasic Biomarker of Aggressive Prostate Cancer and a Metastasis Predictor
inferred← citeshttps://doi.org/10.1016/j.ajur.2018.10.001openalex-snapshot
Current progress and questions in germline genetics of prostate cancer
inferred← citeshttps://doi.org/10.1016/j.bbamcr.2016.02.016openalex-snapshot
The molecular and cellular origin of human prostate cancer
inferred← citeshttps://doi.org/10.1016/j.bbcan.2019.06.002openalex-snapshot
Metastasis as a systemic disease: molecular insights and clinical implications
inferred← citeshttps://doi.org/10.1016/j.bbcan.2025.189367openalex-snapshot
Unraveling metastatic timing: insights and challenges from genomic evolution
inferred← citeshttps://doi.org/10.1016/j.cancergen.2017.08.003openalex-snapshot
Clinical utility of emerging liquid biomarkers in advanced prostate cancer
inferred← citeshttps://doi.org/10.1016/j.ccell.2025.07.008openalex-snapshot
Circulating tumor cells: Blood-based detection, molecular biology, and clinical applications
inferred← citeshttps://doi.org/10.1016/j.cell.2015.05.001openalex-snapshot
Integrative Clinical Genomics of Advanced Prostate Cancer
inferred← citeshttps://doi.org/10.1016/j.cellsig.2016.07.011openalex-snapshot
DAB2IP regulates EMT and metastasis of prostate cancer through targeting PROX1 transcription and destabilizing HIF1α protein
inferred← citeshttps://doi.org/10.1016/j.cels.2024.10.005openalex-snapshot
Tumor architecture and emergence of strong genetic alterations are bottlenecks for clonal evolution in primary prostate cancer
inferred← citeshttps://doi.org/10.1016/j.chest.2023.12.013openalex-snapshot
Sublobar Resection, Stereotactic Body Radiation Therapy, and Percutaneous Ablation Provide Comparable Outcomes for Lung Metastasis-Directed Therapy
inferred← citeshttps://doi.org/10.1016/j.cll.2023.08.003openalex-snapshot
Molecular Pathology of Prostate Cancer
inferred← citeshttps://doi.org/10.1016/j.clon.2017.10.004openalex-snapshot
Incorporating Biomarker Stratification into STAMPEDE: an Adaptive Multi-arm, Multi-stage Trial Platform
inferred← citeshttps://doi.org/10.1016/j.coi.2018.03.018openalex-snapshot
Multiple roles of lymphatic vessels in tumor progression
inferred← citeshttps://doi.org/10.1016/j.coi.2018.04.008openalex-snapshot
The evolving role of lymphatics in cancer metastasis
inferred← citeshttps://doi.org/10.1016/j.critrevonc.2017.12.012openalex-snapshot
Loco-regional treatment for castration-resistant prostate cancer: Is there any rationale? A critical review from the AFU-GETUG
inferred← citeshttps://doi.org/10.1016/j.csbj.2024.08.026openalex-snapshot
UQCRB and LBH are correlated with Gleason score progression in prostate cancer: Spatial transcriptomics and experimental validation
inferred← citeshttps://doi.org/10.1016/j.ctarc.2022.100606openalex-snapshot
Current status and future perspective on the management of metastatic castration-sensitive prostate cancer
inferred← citeshttps://doi.org/10.1016/j.drudis.2015.10.010openalex-snapshot
Clonotyping for precision oncology
inferred← citeshttps://doi.org/10.1016/j.drudis.2018.07.008openalex-snapshot
Discovering novel valid biomarkers and drugs in patient-centric genomic trials: the new epoch of precision surgical oncology
inferred← citeshttps://doi.org/10.1016/j.ebiom.2015.07.017openalex-snapshot
Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study
inferred← citeshttps://doi.org/10.1016/j.ejphar.2022.174807openalex-snapshot
Therapeutic potential of p53 reactivation in prostate cancer: Strategies and opportunities
inferred← citeshttps://doi.org/10.1016/j.euf.2018.01.006openalex-snapshot
Genomic Heterogeneity Within Individual Prostate Cancer Foci Impacts Predictive Biomarkers of Targeted Therapy
inferred← citeshttps://doi.org/10.1016/j.euf.2018.02.015openalex-snapshot
Standard of Care Versus Metastases-directed Therapy for PET-detected Nodal Oligorecurrent Prostate Cancer Following Multimodality Treatment: A Multi-institutional Case-control Study
inferred← citeshttps://doi.org/10.1016/j.euf.2023.02.001openalex-snapshot
Prostate-specific Membrane Antigen Positron Emission Tomography as a Biomarker to Assess Treatment Response in Patients with Advanced Prostate Cancer
inferred← citeshttps://doi.org/10.1016/j.euo.2018.12.005openalex-snapshot
An Accessible and Unique Insight into Metastasis Mutational Content Through Whole-exome Sequencing of Circulating Tumor Cells in Metastatic Prostate Cancer
inferred← citeshttps://doi.org/10.1016/j.euo.2019.07.010openalex-snapshot
Oligometastatic Prostate Cancer: Results of a Dutch Multidisciplinary Consensus Meeting
inferred← citeshttps://doi.org/10.1016/j.euo.2021.02.008openalex-snapshot
A Systematic Review of Prostate Cancer Heterogeneity: Understanding the Clonal Ancestry of Multifocal Disease
inferred← citeshttps://doi.org/10.1016/j.euros.2022.05.011openalex-snapshot
Defining Prostatic Vascular Pedicle Recurrence and the Anatomy of Local Recurrence of Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography
inferred← citeshttps://doi.org/10.1016/j.eururo.2015.05.023openalex-snapshot
A Multi-institutional Analysis of Perioperative Outcomes in 106 Men Who Underwent Radical Prostatectomy for Distant Metastatic Prostate Cancer at Presentation
inferred← citeshttps://doi.org/10.1016/j.eururo.2015.07.011openalex-snapshot
Re: Johan Lindberg, Anna Kristiansen, Peter Wiklund, Henrik Grönberg, Lars Egevad. Tracking the Origin of Metastatic Prostate Cancer. Eur Urol 2015;67:819–22
inferred← citeshttps://doi.org/10.1016/j.eururo.2016.08.018openalex-snapshot
Disrupting the Status Quo in Prostate Cancer Diagnosis
inferred← citeshttps://doi.org/10.1016/j.eururo.2018.05.029openalex-snapshot
Re: MRI-targeted or Standard Biopsy for Prostate-cancer Diagnosis
inferred← citeshttps://doi.org/10.1016/j.eururo.2018.06.004openalex-snapshot
Stereotactic Abative Body Radiotherapy (SABR) for Oligometastatic Prostate Cancer: A Prospective Clinical Trial
inferred← citeshttps://doi.org/10.1016/j.eururo.2018.08.009openalex-snapshot
Multifocal Primary Prostate Cancer Exhibits High Degree of Genomic Heterogeneity
inferred← citeshttps://doi.org/10.1016/j.eururo.2023.10.012openalex-snapshot
The Efficacy and Safety of Metastasis-directed Therapy in Patients with Prostate Cancer: A Systematic Review and Meta-analysis of Prospective Studies
inferred← citeshttps://doi.org/10.1016/j.gendis.2025.101983openalex-snapshot
Uncovering genes driving developmental stage progression in prostate cancer through spatial transcriptomics
inferred← citeshttps://doi.org/10.1016/j.gpb.2022.02.004openalex-snapshot
LDHA Desuccinylase Sirtuin 5 as a Novel Cancer Metastatic Stimulator in Aggressive Prostate Cancer
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2017.03.031openalex-snapshot
Exosomes and Exosomal MicroRNAs in Prostate Cancer Radiation Therapy
inferred← citeshttps://doi.org/10.1016/j.isci.2023.108429openalex-snapshot
Visium spatial transcriptomics reveals intratumor heterogeneity and profiles of Gleason score progression in prostate cancer
inferred← citeshttps://doi.org/10.1016/j.isci.2024.111351openalex-snapshot
Spatial transcriptomics identifies RBM39 as a gene associated with Gleason score progression in prostate cancer
inferred← citeshttps://doi.org/10.1016/j.jsbmb.2016.05.006openalex-snapshot
Stem cells and the role of ETS transcription factors in the differentiation hierarchy of normal and malignant prostate epithelium
inferred← citeshttps://doi.org/10.1016/j.neo.2016.01.007openalex-snapshot
Rat Prostate Tumor Cells Progress in the Bone Microenvironment to a Highly Aggressive Phenotype
inferred← citeshttps://doi.org/10.1016/j.neo.2018.07.001openalex-snapshot
Mutational Intratumor Heterogeneity is a Complex and Early Event in the Development of Adult T-cell Leukemia/Lymphoma
inferred← citeshttps://doi.org/10.1016/j.path.2021.05.004openalex-snapshot
Molecular Pathology of Prostate Cancer
inferred← citeshttps://doi.org/10.1016/j.pharmthera.2019.03.007openalex-snapshot
Limiting tumor seeding as a therapeutic approach for metastatic disease
inferred← citeshttps://doi.org/10.1016/j.prp.2018.08.031openalex-snapshot
ERG alterations and mTOR pathway activation in primary prostate carcinomas developing castration-resistance
inferred← citeshttps://doi.org/10.1016/j.radonc.2020.08.011openalex-snapshot
A combined biological and clinical rationale for evaluating metastasis directed therapy in the management of oligometastatic prostate cancer
inferred← citeshttps://doi.org/10.1016/j.semcancer.2017.03.009openalex-snapshot
Cellular determinants and microenvironmental regulation of prostate cancer metastasis
inferred← citeshttps://doi.org/10.1016/j.semcancer.2020.12.016openalex-snapshot
LRIG1, a regulator of stem cell quiescence and a pleiotropic feedback tumor suppressor
inferred← citeshttps://doi.org/10.1016/j.semcancer.2021.06.016openalex-snapshot
Prostate cancer cell heterogeneity and plasticity: Insights from studies of genetically-engineered mouse models
inferred← citeshttps://doi.org/10.1016/j.semradonc.2025.04.011openalex-snapshot
Debate 3: Oligometastatic Hormone Sensitive Prostate Cancer Management: Systemic Therapy Approach
inferred← citeshttps://doi.org/10.1016/j.str.2019.06.001openalex-snapshot
Building a Hybrid Physical-Statistical Classifier for Predicting the Effect of Variants Related to Protein-Drug Interactions
inferred← citeshttps://doi.org/10.1016/j.tig.2016.07.002openalex-snapshot
Sequencing Structural Variants in Cancer for Precision Therapeutics
inferred← citeshttps://doi.org/10.1016/j.tranon.2020.100909openalex-snapshot
Transitional dynamics of cancer stem cells in invasion and metastasis
inferred← citeshttps://doi.org/10.1016/j.tranon.2021.101311openalex-snapshot
Intratumor heterogeneity and clonal evolution revealed in castration-resistant prostate cancer by longitudinal genomic analysis
inferred← citeshttps://doi.org/10.1016/j.trecan.2015.07.009openalex-snapshot
Surviving at a Distance: Organ-Specific Metastasis
inferred← citeshttps://doi.org/10.1016/j.trecan.2019.05.008openalex-snapshot
Clonal Evolution and Epithelial Plasticity in the Emergence of AR-Independent Prostate Carcinoma
inferred← citeshttps://doi.org/10.1016/j.trecan.2023.03.002openalex-snapshot
Insights into the metastatic cascade through research autopsies
inferred← citeshttps://doi.org/10.1016/j.urology.2021.09.004openalex-snapshot
Access and Representation: A Narrative Review of the Disparities in Access to Clinical Trials and Precision Oncology in Black men with Prostate Cancer
inferred← citeshttps://doi.org/10.1016/j.urolonc.2016.02.016openalex-snapshot
Disease volume and distribution as drivers of treatment decisions in metastatic prostate cancer: From chemohormonal therapy to stereotactic ablative radiotherapy of oligometastases
inferred← citeshttps://doi.org/10.1016/j.urolonc.2017.01.001openalex-snapshot
Role of radical prostatectomy in metastatic prostate cancer: A review
inferred← citeshttps://doi.org/10.1016/j.urolonc.2017.11.017openalex-snapshot
Predicting therapy response and resistance in metastatic prostate cancer with circulating tumor DNA
inferred← citeshttps://doi.org/10.1016/j.urolonc.2018.05.008openalex-snapshot
Intratumor heterogeneity in prostate cancer
inferred← citeshttps://doi.org/10.1016/j.urolonc.2018.11.009openalex-snapshot
Utilizing precision medicine to modulate the prostate tumor microenvironment and enhance immunotherapy
inferred← citeshttps://doi.org/10.1016/j.urolonc.2020.03.001openalex-snapshot
High prevalence of DNA damage repair gene defects and TP53 alterations in men with treatment-naïve metastatic prostate cancer –Results from a prospective pilot study using a 37 gene panel
inferred← citeshttps://doi.org/10.1016/j.urolonc.2021.06.024openalex-snapshot
Mutations in TP53 or DNA damage repair genes define poor prognostic subgroups in primary prostate cancer
inferred← citeshttps://doi.org/10.1016/j.urolonc.2024.01.032openalex-snapshot
Comparative analysis of prognosis and gene expression in prostate cancer patients with site-specific visceral metastases
inferred← citeshttps://doi.org/10.1021/acsabm.9b00940openalex-snapshot
Materials-Based Approach for Interrogating Human Prostate Cancer Cell Adhesion and Migratory Potential Using a Fluoroalkylsilica Culture Surface
inferred← citeshttps://doi.org/10.1021/acsami.5b08422openalex-snapshot
A Protein-Corona-Free T1–T2 Dual-Modal Contrast Agent for Accurate Imaging of Lymphatic Tumor Metastasis
inferred← citeshttps://doi.org/10.1038/bjc.2015.234openalex-snapshot
The genomic evolution of human prostate cancer
inferred← citeshttps://doi.org/10.1038/cddis.2017.225openalex-snapshot
Human cancer-associated fibroblasts enhance glutathione levels and antagonize drug-induced prostate cancer cell death
inferred← citeshttps://doi.org/10.1038/modpathol.2017.166openalex-snapshot
The Genomics of Prostate Cancer: emerging understanding with technologic advances
inferred← citeshttps://doi.org/10.1038/mt.2015.85openalex-snapshot
Arresting the Colonial Destiny of Metastatic Seeds with DNA Aptamers
inferred← citeshttps://doi.org/10.1038/ncomms11845openalex-snapshot
Spatial niche formation but not malignant progression is a driving force for intratumoural heterogeneity
inferred← citeshttps://doi.org/10.1038/ncomms12008openalex-snapshot
Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer
inferred← citeshttps://doi.org/10.1038/ncomms14944openalex-snapshot
Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations
inferred← citeshttps://doi.org/10.1038/ng.3764openalex-snapshot
Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer
inferred← citeshttps://doi.org/10.1038/nm.4475openalex-snapshot
Positively selected enhancer elements endow osteosarcoma cells with metastatic competence
inferred← citeshttps://doi.org/10.1038/nrc.2016.44openalex-snapshot
Bone metastasis: the importance of the neighbourhood
inferred← citeshttps://doi.org/10.1038/nrc.2017.126openalex-snapshot
Genetic insights into the morass of metastatic heterogeneity
inferred← citeshttps://doi.org/10.1038/nrclinonc.2016.76openalex-snapshot
Translational and clinical implications of the genetic landscape of prostate cancer
inferred← citeshttps://doi.org/10.1038/nrclinonc.2017.166openalex-snapshot
Tumour heterogeneity and resistance to cancer therapies
inferred← citeshttps://doi.org/10.1038/nrg.2016.170openalex-snapshot
The evolution of tumour phylogenetics: principles and practice
inferred← citeshttps://doi.org/10.1038/onc.2016.223openalex-snapshot
Androgen deprivation leads to increased carbohydrate metabolism and hexokinase 2-mediated survival in Pten/Tp53-deficient prostate cancer
inferred← citeshttps://doi.org/10.1038/pcan.2016.52openalex-snapshot
The impact of local treatment of the primary tumor site in node positive and metastatic prostate cancer patients
inferred← citeshttps://doi.org/10.1038/s41388-026-03944-0openalex-snapshot
Clinical metastatic cancer from initiation to colonization: emerging challenges and breakthroughs
inferred← citeshttps://doi.org/10.1038/s41391-017-0027-4openalex-snapshot
p53 status in the primary tumor predicts efficacy of subsequent abiraterone and enzalutamide in castration-resistant prostate cancer
inferred← citeshttps://doi.org/10.1038/s41391-021-00379-4openalex-snapshot
MSH2-deficient prostate tumours have a distinct immune response and clinical outcome compared to MSH2-deficient colorectal or endometrial cancer
inferred← citeshttps://doi.org/10.1038/s41413-023-00260-1openalex-snapshot
Bone serves as a transfer station for secondary dissemination of breast cancer
inferred← citeshttps://doi.org/10.1038/s41416-018-0321-5openalex-snapshot
Exploring the transcriptome of hormone-naive multifocal prostate cancer and matched lymph node metastases
inferred← citeshttps://doi.org/10.1038/s41416-020-01127-6openalex-snapshot
Genomic control of metastasis
inferred← citeshttps://doi.org/10.1038/s41416-025-03323-8openalex-snapshot
Transient centrosome loss in cultured prostate epithelial cells induces chromosomal instability to produce an oncogenic genotype that correlates with poor clinical outcomes
inferred← citeshttps://doi.org/10.1038/s41419-022-05211-yopenalex-snapshot
Modelling aggressive prostate cancers of young men in immune-competent mice, driven by isogenic Trp53 alterations and Pten loss
inferred← citeshttps://doi.org/10.1038/s41467-018-04208-6openalex-snapshot
The effects of mutational processes and selection on driver mutations across cancer types
inferred← citeshttps://doi.org/10.1038/s41467-018-04724-5openalex-snapshot
Spatial maps of prostate cancer transcriptomes reveal an unexplored landscape of heterogeneity
inferred← citeshttps://doi.org/10.1038/s41467-020-14351-8openalex-snapshot
Inferring structural variant cancer cell fraction
inferred← citeshttps://doi.org/10.1038/s41467-020-18843-5openalex-snapshot
Prostate cancer evolution from multilineage primary to single lineage metastases with implications for liquid biopsy
inferred← citeshttps://doi.org/10.1038/s41467-021-27794-4openalex-snapshot
Genomic alterations and evolution of cell clusters in metastatic invasive micropapillary carcinoma of the breast
inferred← citeshttps://doi.org/10.1038/s41568-019-0185-xopenalex-snapshot
An analysis of genetic heterogeneity in untreated cancers
inferred← citeshttps://doi.org/10.1038/s41568-022-00536-4openalex-snapshot
Biology, vulnerabilities and clinical applications of circulating tumour cells
inferred← citeshttps://doi.org/10.1038/s41578-021-00315-xopenalex-snapshot
Multifunctional biomolecule nanostructures for cancer therapy
inferred← citeshttps://doi.org/10.1038/s41585-018-0020-2openalex-snapshot
Translational models of prostate cancer bone metastasis
inferred← citeshttps://doi.org/10.1038/s41585-019-0178-2openalex-snapshot
Merging new-age biomarkers and nanodiagnostics for precision prostate cancer management
inferred← citeshttps://doi.org/10.1038/s41585-020-00400-wopenalex-snapshot
Genomic and phenotypic heterogeneity in prostate cancer
inferred← citeshttps://doi.org/10.1038/s41585-020-0310-3openalex-snapshot
Harnessing the potential of multimodal radiotherapy in prostate cancer
inferred← citeshttps://doi.org/10.1038/s41585-022-00677-zopenalex-snapshot
Experimental in vitro, ex vivo and in vivo models in prostate cancer research
inferred← citeshttps://doi.org/10.1038/s41586-022-05023-2openalex-snapshot
Spatially resolved clonal copy number alterations in benign and malignant tissue
inferred← citeshttps://doi.org/10.1038/s41588-018-0318-2openalex-snapshot
Molecular landmarks of tumor hypoxia across cancer types
inferred← citeshttps://doi.org/10.1038/s41592-020-01013-2openalex-snapshot
A practical guide to cancer subclonal reconstruction from DNA sequencing
inferred← citeshttps://doi.org/10.1038/s41598-017-04897-xopenalex-snapshot
Mutations in BRCA2 and taxane resistance in prostate cancer
inferred← citeshttps://doi.org/10.1038/s41598-017-05623-3openalex-snapshot
Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer
inferred← citeshttps://doi.org/10.1038/s41598-018-35417-0openalex-snapshot
High-throughput screens identify HSP90 inhibitors as potent therapeutics that target inter-related growth and survival pathways in advanced prostate cancer
inferred← citeshttps://doi.org/10.1038/s41598-022-07394-yopenalex-snapshot
Radiotherapy alters expression of molecular targets in prostate cancer in a fractionation- and time-dependent manner
inferred← citeshttps://doi.org/10.1038/s41698-024-00713-8openalex-snapshot
Integrated multi-omics assessment of lineage plasticity in a prostate cancer patient with brain and dural metastases
inferred← citeshttps://doi.org/10.1038/s42003-020-01529-5openalex-snapshot
Reciprocal interactions between tumour cell populations enhance growth and reduce radiation sensitivity in prostate cancer
inferred← citeshttps://doi.org/10.1038/s43018-020-00141-0openalex-snapshot
Accelerating precision medicine in metastatic prostate cancer
inferred← citeshttps://doi.org/10.1038/s43018-023-00711-yopenalex-snapshot
Aneuploidy and complex genomic rearrangements in cancer evolution
inferred← citeshttps://doi.org/10.1038/srep15205openalex-snapshot
Three-dimensional chemotaxis-driven aggregation of tumor cells
inferred← citeshttps://doi.org/10.1038/srep33918openalex-snapshot
Comparing nodal versus bony metastatic spread using tumour phylogenies
inferred← citeshttps://doi.org/10.1038/srep43813openalex-snapshot
Genomic Analyses of Breast Cancer Progression Reveal Distinct Routes of Metastasis Emergence
inferred← citeshttps://doi.org/10.1053/j.seminoncol.2022.09.005openalex-snapshot
A systematic review and meta-analysis on non-metastatic castration resistant prostate cancer: The radiation oncologist's perspective
inferred← citeshttps://doi.org/10.1053/j.semnuclmed.2025.11.025openalex-snapshot
Therapy strategies to defeat prostate cancer heterogeneity
inferred← citeshttps://doi.org/10.1073/pnas.1521674112openalex-snapshot
Functional screen identifies kinases driving prostate cancer visceral and bone metastasis
inferred← citeshttps://doi.org/10.1073/pnas.1910255116openalex-snapshot
Loss of p53 function at late stages of tumorigenesis confers ARF-dependent vulnerability to p53 reactivation therapy
inferred← citeshttps://doi.org/10.1073/pnas.2014639117openalex-snapshot
4-Hydroxyacetophenone modulates the actomyosin cytoskeleton to reduce metastasis
inferred← citeshttps://doi.org/10.1080/14737159.2017.1345627openalex-snapshot
Molecular biomarkers to guide precision medicine in localized prostate cancer
inferred← citeshttps://doi.org/10.1080/17474124.2021.1967144openalex-snapshot
Clinical utility of clonal origin determination in managing recurrent hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1088/1361-6560/ab0924openalex-snapshot
Computational modelling of resistance and associated treatment response heterogeneity in metastatic cancers
inferred← citeshttps://doi.org/10.1093/annonc/mdv332openalex-snapshot
Academically led clinical trials: challenges and opportunities
inferred← citeshttps://doi.org/10.1093/annonc/mdx023openalex-snapshot
Data resources for the identification and interpretation of actionable mutations by clinicians
inferred← citeshttps://doi.org/10.1093/annonc/mdx182openalex-snapshot
Copy number alterations assessed at the single-cell level revealed mono- and polyclonal seeding patterns of distant metastasis in a small-cell lung cancer patient
inferred← citeshttps://doi.org/10.1093/carcin/bgw055openalex-snapshot
Understanding mutagenesis through delineation of mutational signatures in human cancer
inferred← citeshttps://doi.org/10.1093/gbe/evab276openalex-snapshot
Tumors Are Evolutionary Island-Like Ecosystems
inferred← citeshttps://doi.org/10.1093/gigascience/giab036openalex-snapshot
MesKit: a tool kit for dissecting cancer evolution of multi-region tumor biopsies through somatic alterations
inferred← citeshttps://doi.org/10.1093/jnci/djx118openalex-snapshot
Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer
inferred← citeshttps://doi.org/10.1093/nar/gkv1166openalex-snapshot
Cross talk of tyrosine kinases with the DNA damage signaling pathways
inferred← citeshttps://doi.org/10.1093/oncolo/oyac198openalex-snapshot
The Value of Phenotypic Precision Medicine in Prostate Cancer
inferred← citeshttps://doi.org/10.1097/ju.0000000000003890openalex-snapshot
Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part III: Salvage Therapy After Radiotherapy or Focal Therapy, Pelvic Nodal Recurrence and Oligometastasis, and Future Directions
inferred← citeshttps://doi.org/10.1097/mou.0000000000000278openalex-snapshot
Precision medicine for advanced prostate cancer
showing the first 200 of 370 · page through all 370
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.